Participate in AMGA Implementation Research

By its nature, implementation science fosters innovations that originate at the clinic level in response to real-world challenges. AMGA Analytics’ studies combine quantitative data (Optum® data assets) with qualitative data collected from AMGA member organizations. This mixed methods approach adds richness to the data by helping better uncover and understand the meaning behind the quantitative data, the nuances and reasons driving behavior and process changes.

AMGA Research Opportunities

AMGA works with members, AMGA Corporate Partners, and distinguished national research partners to tackle major challenges healthcare organizations are facing today. Below are current research projects that have implications for AMGA member organizations. Please let us know if your organization has an interest in participating in research related to these projects. We also have another major research project in the pipeline that will include AMGA members.

Become an AMGA implementation research partner.

Current Research Opportunities

  • Chronic Pain Management and Opioid Prescribing: AMGA is collaborating with Abt Associates to evaluate the impact of clinical practice guidelines and health system policies on chronic pain management, opioid prescribing, and medication assisted treatment (MAT). The Centers for Disease Control and Prevention (CDC) is funding research that will include 10 to 12 AMGA member organizations. The goal is to gather information about how members are implementing guidelines/polices and the effect they are having on pain management practices, clinician-patient communication, and patient outcomes. Findings will be disseminated to help other AMGA members who are struggling in addressing and responding to the national opioid epidemic.
  • Piloting Predictive Models Within the Clinical Workflow
    • Enhanced Decision Making for Patients with Prediabetes: With funding from the Patient-Centered Outcomes Institute (PCORI), AMGA is working with Mercy (Midwest) and Premier Medical Associates (Pennsylvania) to apply a model created at Tuft’s Predictive Analytics and Comparative Effectiveness (PACE) Center. The model uses data available in the electronic health record (EHR) to estimate individualized treatment benefits of taking metformin or participating in the Diabetes Prevention Program. With its emphasis on shared decision-making, the model is already making a difference. PCORI provided additional funding for AMGA to implement the model at Mercy via a cloud-hosted SMART app using FHIR resources. This EHR interoperability technology allows provider organizations to embed sophisticated predictive models in the clinical workflow within any leading EHR, enabling rapid scalability to other AMGA members.
  • Chronic Kidney Disease Patch for ASCVD Risk Calculator: AMGA Analytics, in partnership with the Welch Center at Johns Hopkins University (JHU), has received funding for practical implementation of a CKD patch tool (in development at JHU) for the AHA/ACC ASCVD risk calculator that improves identification of people at risk for ASCVD by integrating kidney function data into the risk calculation. The patch will be applied via a SMART app using FHIR resources for smoother user interface in the EHR. AMGA is leading development of the software (predictive model engine), EHR integration, and validation of the tool that will expand use into practice and the clinical workflow. One AMGA integrated health system will implement and pilot test with providers and patients.
    • Evaluation of the Implementation of an at-homeUrinalysis Kit: Member group honorarium: AMGA Analytics will engage up to two AMGA member organizations in a study evaluating implementation and outcomes with use of a’s proprietary Smartphone Urinalysis Kit in an at-risk population. The overall study goal will be to identify 3,000 to 5,000 patients who qualify to receive the  at home kit and to collect data over a 3-month period on patients. Patients who qualify must have documented type 2 diabetes or non-diabetic hypertension who have not had an albumin-to-creatinine Ratio (ACR) or a proteinuria test reported in the past 12 months. Participating AMGA member group(s) will receive and honorarium of $10,000 if the data is not integrated into EHR and $15,000 with EHR integration

Research Opportunities in the Pipeline

  • Supporting Transformation to a Value-Based Healthcare System: AMGA Analytics has registered as a subcontractor with the Federal government so we can expand research opportunities with the Agency for Health Research and Quality (AHRQ) Action IV program. ACTION  IV is a five-year contracting vehicle that will focus on field- based, real-world informed development, testing, and implementation of new approaches for improving care. AHRQ has added the following new emerging areas of focus: supporting transformation to a value-based healthcare system; advancing data-driven approaches to population health management and patient-centered care; supporting

    Learning Health Systems in the use of data to improve care; and promoting whole person, 360 care. We anticipate notification on the ACTION IV program to be announced at the beginning of summer 2020.